Principal Financial Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-352,600
| Closed | -$2.93M | – | 2236 |
|
|
2024
Q3 | $2.93M | Sell |
352,600
-313,587
| -47% | -$2.61M | ﹤0.01% | 1711 |
|
|
2024
Q2 | $4.77M | Buy |
666,187
+255,990
| +62% | +$1.83M | ﹤0.01% | 1566 |
|
|
2024
Q1 | $3.56M | Buy |
410,197
+398,306
| +3,350% | +$3.45M | ﹤0.01% | 1673 |
|
|
2023
Q4 | $77.9K | Hold |
11,891
| – | – | ﹤0.01% | 2295 |
|
|
2023
Q3 | $119K | Buy |
11,891
+797
| +7% | +$7.97K | ﹤0.01% | 2257 |
|
|
2023
Q2 | $138K | Sell |
11,094
-649
| -6% | -$8.07K | ﹤0.01% | 2235 |
|
|
2023
Q1 | $165K | Sell |
11,743
-2,206
| -16% | -$30.9K | ﹤0.01% | 2219 |
|
|
2022
Q4 | $200K | Sell |
13,949
-40,192
| -74% | -$575K | ﹤0.01% | 2196 |
|
|
2022
Q3 | $1.38M | Sell |
54,141
-587,208
| -92% | -$15M | ﹤0.01% | 1785 |
|
|
2022
Q2 | $18.2M | Buy |
641,349
+139,667
| +28% | +$3.97M | 0.01% | 888 |
|
|
2022
Q1 | $17.7M | Sell |
501,682
-69,025
| -12% | -$2.43M | 0.01% | 1001 |
|
|
2021
Q4 | $23.9M | Sell |
570,707
-44,634
| -7% | -$1.87M | 0.01% | 824 |
|
|
2021
Q3 | $30.2M | Buy |
615,341
+122,409
| +25% | +$6.01M | 0.02% | 649 |
|
|
2021
Q2 | $20.6M | Buy |
492,932
+486,275
| +7,305% | +$20.3M | 0.01% | 955 |
|
|
2021
Q1 | $237K | Buy |
+6,657
| New | +$237K | ﹤0.01% | 2338 |
|